Advanced search
Publication Cover
Leukemia & Lymphoma Volume 10, 1993 - Issue sup1
Submit an article Journal homepage
11
Views
10
CrossRef citations to date
0
Altmetric
Original Article

2-Chlorodeoxyadenosine: A New Nucleoside Agent Effective in the Treatment of Lymphoid Malignancies

Alan Saven Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center Scripps Clinic and Research Foundation, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA
&
Lawrence D. Piro Division of Hematology/Oncology, Ida M. and Cecil H. Green Cancer Center Scripps Clinic and Research Foundation, 10666 North Torrey Pines Road, La Jolla, CA, 92037, USA
Pages 43-49 | Published online: 01 Jul 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marco Montillo, Francesca Ricci, Sara Miqueleiz, Alessandra Tedeschi & Enrica Morra. (2008) Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL). Biologics: Targets and Therapy 2:1, pages 41-52.
Read now

Articles from other publishers (9)

Mukundan Baskar Mannargudi & Subrata Deb. (2017) Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?. Journal of Cancer Research and Clinical Oncology 143:8, pages 1499-1529.
Crossref
Michael W Lee, William B Parker & Bo Xu. (2013) New insights into the synergism of nucleoside analogs with radiotherapy. Radiation Oncology 8:1.
Crossref
Anthony D HoManfred Hensel. (2006) Pentostatin and purine analogs for indolent lymphoid malignancies. Future Oncology 2:2, pages 169-183.
Crossref
Claire E Dearden & Francine M Foss. (2003) Peripheral T- cell lymphomas: diagnosis and management. Hematology/Oncology Clinics of North America 17:6, pages 1351-1366.
Crossref
A.D. Ho, S. Suciu, P. Stryckmans, F. De Cataldo, R. Willemze, J. Thaler, M. Peetermans, H. Döhner, G. Solbu, M. Dardenne & R. Zittoun. (1999) Pentostatin in T-cell malignancies – a phase II trial of the EORTC. Annals of Oncology 10:12, pages 1493-1498.
Crossref
Geoffrey R. Weiss, John G. Kuhn, Jinee Rizzo, Lon S. Smith, Gladys I. Rodriguez, John R. Eckardt, Howard A. Burris, Suzanne Fields, Karla VanDenBerg & Daniel D. Von Hoff. (1995) A Phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors. Cancer Chemotherapy and Pharmacology 35:5, pages 397-402.
Crossref
Maria K. Angelopoulou & Gerassimos A. Pangalis. 1995. Malignant Lymphomas: Biology and Treatment. Malignant Lymphomas: Biology and Treatment 75 102 .
H. -J. Guchelaar, D. J. Richel & M. R. Schaafsma. (1994) Clinical and toxicological aspects of the antineoplastic drug cladribine: A review. Annals of Hematology 69:5, pages 223-230.
Crossref
. (1994) Tumor Lysis Syndrome after Treatment of Chronic Lymphocytic Leukemia with Cladribine. New England Journal of Medicine 330:15, pages 1090-1090.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.